LONDON - Wednesday, September 21st 2016 [ME NewsWire]
(BUSINESS
WIRE)--Smith & Nephew (LSE:SN, NYSE:SNN), the
global medical technology business, highlights three scientific symposia at World
Union of Wound Health Societies (WUWHS) on 25–29 September 2016 in Florence,
Italy. These symposia reinforce Smith & Nephew’s commitment to supporting
healthcare professionals by conducting and effectively communicating research
in areas of clinical practice that can enable improved outcomes for patients.
The first symposia will focus on PICO™, a unique
single-use negative pressure wound therapy system (sNPWT), and its role in
reducing surgical site complications. Through a wealth of clinical evidence,
PICO™ is rapidly becoming a leading choice in NPWT due to its ability to manage
a wide range of wounds at risk of complications in a clinical and cost
effective way. In a recent study, using PICO™ reduced superficial surgical
complications four-fold (from 8% to 2%) and significantly reduced the number of
total dressing changes required per patient.1
“Infections can occur at relatively higher than
expected rate among patients associated with co-morbid risk factors who have
surgery, resulting in considerable social, healthcare and wider economic
implications,” says Dr Risal Djohan, Department of Plastic Surgery,
Cleveland Clinic, USA . “The clinical evidence that will be presented at WUWHS
will further demonstrate how PICO™ could potentially shift the treatment
paradigm to heal most types of wounds more efficiently, leading to positive
patient outcomes.”
In Smith & Nephew’s second symposia, a panel
of 10 global scientific and clinical experts will present an evolving consensus
statement, reinforcing the need to better understand the role of biofilms in
delayed wound healing and the challenges it presents.
Finally, through the third symposia – Pressure
Ulcer Prevention: Driving to Zero – leading experts will discuss prioritising programmes
to significantly reduce hospital-acquired pressure ulcers.
Dr. Niz Islam, Vice President, Scientific &
Medical Affairs, said “Smith & Nephew is proud to support this important
gathering of the community to share data and new practices in advanced wound
management. We are bringing together wound experts to present clinically
relevant data in symposia on three areas of importance to the community; NPWT,
pressure ulcer prevention protocols and a consensus expert panel on biofilms.
Through these and other new clinical evidence we aim to improve outcomes for
patients, healthcare professionals and health care systems.”
Smith & Nephew is a diamond sponsor of
World Union of Wound Healing Societies Meeting
About Smith & Nephew’s WUWHS Symposia
|
Symposia
|
Date / Location
|
Presenters
|
|
Pressure Ulcer
Prevention: Driving to Zero
|
27 September 2016
12:15 – 13:15
Hall Brunelleschi
|
M. Collier (UK), M.
Sammon (USA), J. Frumenti (USA)
|
|
Surgical
Incision Management:
Prevention of Surgical Wound Complications with Single-Use NPWT (PICO™) |
28 September 2016
12:15 – 13:45
Hall Michelangelo
|
M. Sugrue (IRE), R.
Djohan (USA), N. Hyldig (DK),
S. Nair (USA) |
|
Wound Biofilm Consensus:
Recommendations from an Expert Panel
|
29 September 2016
8:30 – 9:30
Hall Donatello
|
G. Schultz (USA), T.
Bjarnsholt (DK), R. Wolcott (USA)
|
- Ends -
Enquiries
|
Media
|
|
|
Karley Ura
Madano
|
+44 (0) 20 3595 2415
|
|
|
|
|
Jaclyn Confalone
Madano
|
+44 (0) 20 3595 2441
|
About Smith & Nephew
Smith & Nephew is a
global medical technology business dedicated to helping healthcare
professionals improve people's lives. With leadership positions in Orthopaedic
Reconstruction, Advanced Wound Management, Sports Medicine and Trauma &
Extremities, Smith & Nephew has around 15,000 employees and a presence in
more than 100 countries. Annual sales in 2015 were more than $4.6 billion.
Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN).
For more information about
Smith & Nephew, please visit our website www.smith-nephew.com, follow
@SmithNephewplc on Twitter or visit
SmithNephewplc on Facebook.com.
For more information on Smith & Nephew’s
presence at WUWHS 2016 please visit us at: http://www.smith-nephew.com/wuwhs2016/.
Forward-looking Statements
This
document may contain forward-looking statements that may or may not prove
accurate. For example, statements regarding expected revenue growth and trading
margins, market trends and our product pipeline are forward-looking statements.
Phrases such as "aim", "plan", "intend",
"anticipate", "well-placed", "believe",
"estimate", "expect", "target",
"consider" and similar expressions are generally intended to identify
forward-looking statements. Forward-looking statements involve known and
unknown risks, uncertainties and other important factors that could cause
actual results to differ materially from what is expressed or implied by the
statements. For Smith & Nephew, these factors include: economic and
financial conditions in the markets we serve, especially those affecting health
care providers, payers and customers; price levels for established and
innovative medical devices; developments in medical technology; regulatory
approvals, reimbursement decisions or other government actions; product defects
or recalls or other problems with quality management systems or failure to
comply with related regulations; litigation relating to patent or other claims;
legal compliance risks and related investigative, remedial or enforcement
actions; disruption to our supply chain or operations or those of our
suppliers; competition for qualified personnel; strategic actions, including
acquisitions and dispositions, our success in performing due diligence, valuing
and integrating acquired businesses; disruption that may result from
transactions or other changes we make in our business plans or organisation to
adapt to market developments; and numerous other matters that affect us or our
markets, including those of a political, economic, business, competitive or
reputational nature. Please refer to the documents that Smith & Nephew has
filed with the U.S. Securities and Exchange Commission under the U.S.
Securities Exchange Act of 1934, as amended, including Smith & Nephew's
most recent annual report on Form 20-F, for a discussion of certain of these
factors. Any forward-looking statement is based on information available to
Smith & Nephew as of the date of the statement. All written or oral
forward-looking statements attributable to Smith & Nephew are qualified by
this caution. Smith & Nephew does not undertake any obligation to update or
revise any forward-looking statement to reflect any change in circumstances or
in Smith & Nephew's expectations.
◊ Trademark of Smith & Nephew. Certain marks
registered US Patent and Trademark Office.
References
Karlakki, S. et al. (2016).
Incisional negative pressure wound dressings (NPWTd) in routine primary hip and
knee replacements – A randomised controlled trial. Bone and Joint Research
*source: ME NewsWire
The release can be read online: http://me-newswire.net/news/18683/en
Contacts:
Madano
Karley Ura, +44 (0) 20 3595 2415
or
Jaclyn Confalone, +44 (0) 20 3595
2441
No comments:
Post a Comment